PUBLIC COMPANY
saveVaccine Company Inc
updated 4mo ago
community read0 votes
🐶 often sniffed alongside
top 2pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Trend of women-led M&A fades in 2026 with just two deals so farLast year, 11 major M&A deals were signed with women-led biotechs. The industry is nowhere near on track to meet that bar for 2026.biospace · 4d ago
- Chutes & Ladders—Legend poaches Novartis vet to boost commercial potentialAfter former Legend Biotech CEO Ying Huang, Ph.D., left the company suddenly in July, Legend has found its permanent CEO, poaching Novartis veteran Ingrid Zhang as the CAR-T specialist eyes its nex…fiercebiotech · 16d ago
- Chutes & Ladders—Longtime Takeda R&D chief to depart next JuneTakeda President of Research and Development Andy Plump, M.D., Ph.D., is leaving the company in June after twelve years in the position.fiercebiotech · 23d ago
- Luma locks down 15-year, $410M fund for life science investmentsLuma Group announced the final close of its inaugural life sciences venture capital fund totaling $410 million.fiercebiotech · 25d ago
- Lilly pens deal with Gateway Labs resident Amplitude for RNA vaccine platform for infectious diseaseEli Lilly has turned to one of its Gateway Labs residents to help the Big Pharma develop trans-amplifying RNA (taRNA) vaccines for infectious diseases.fiercebiotech · 1mo ago
comments(0)
5-min edit window · permanent after that